Drug Profile
Interferon-gamma gene therapy
Latest Information Update: 15 Aug 2007
Price :
$50
*
At a glance
- Originator Chiron Technologies; Nonindustrial source
- Developer Chiron Corporation; Chiron Technologies; Nonindustrial source
- Class Cytokine genes; Gene therapies; Interferons
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Malignant melanoma; Neuroblastoma